Loading chat...
IN HB1177
Bill
Status
1/7/2016
Primary Sponsor
Cindy Kirchhofer
Click for details
AI Summary
HB 1177 Summary
-
Requires the Indiana Department of Health to develop a strategic plan to identify and significantly reduce morbidity and mortality from human papillomavirus (HPV)-associated cancers, effective July 1, 2016.
-
Department must collaborate with the Office of the Secretary of Family and Social Services, Indiana University Simon Cancer Institute, University of Notre Dame Harper Research Institute, and Purdue University Center for Cancer Research.
-
Department may establish workgroups including healthcare providers, physicians, cancer epidemiologists, educators, HPV cancer survivors, and community-based organizations to inform the strategic plan.
-
Strategic plan must address barriers to prevention and screening, vaccination methods (excluding mandates), screening technologies, cost estimates, and actions to increase vaccination and screening rates with implementation schedules.
-
Department must deliver a written report to the governor and general assembly by December 31, 2017, including the strategic plan and recommendations on goal implementation and schedule compliance; chapter expires January 1, 2018.
Legislative Description
Cancers associated with human papillomavirus. Requires the state department of health (department) to develop a strategic plan to identify and significantly reduce morbidity and mortality from cancers associated with human papillomavirus. Requires the department to collaborate with the family and social services administration and certain cancer facilities. Allows the department to establish workgroups. Establishes requirements for the department in developing the strategic plan. Requires that a report on the strategic plan and recommendations on goal implementation and schedule compliance must be delivered to the governor and general assembly.
Last Action
Representative Sullivan added as coauthor
2/1/2016